Divis Laboratories has undergone an inspection by the USFDA, with no major observations, for its Unit-II at Chippada village, Bheemunipatnam Mandal, near Visakhapatnam in state of Andhra Pradesh during June, 2014. The audit concluded with one observation primarily about further improvement of existing procedure. The purpose of this inspection was for Custom manufactured product.
Divis Laboratories, together with its subsidiaries, engaged in the manufacture and sale of active pharma ingredients (APIs) and intermediates for the pharmaceutical industry in India and worldwide.
